Abstract
Twenty years ago the concept that immunological mechanisms might regulate carcinogenesis was highly controversial. Today this concept survives in modified form and continues to evolve as our knowledge of the immune system, the etiology of cancer, and tumor antigens expands. This review illustrates how our ideas about immune surveillance have changed in recent years and considers the significance of these changes for the future directions of cancer immunobiology.
Keywords
MeSH Terms
Affiliated Institutions
Related Publications
Does the Immune System See Tumors as Foreign or Self?
Given the vast number of genetic and epigenetic changes associated with carcinogenesis, it is clear that tumors express many neoantigens. A central question in cancer immunology...
Immunobiology of Dendritic Cells
Dendritic cells (DCs) are antigen-presenting cells with a unique ability to induce primary immune responses. DCs capture and transfer information from the outside world to the c...
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
The role of the adaptive immune response in controlling the growth and recurrence of human tumors has been controversial. We characterized the tumor-infiltrating immune cells in...
Coinhibitory Pathways in Immunotherapy for Cancer
The immune system is capable of recognizing tumors and eliminates many early malignant cells. However, tumors evolve to evade immune attack, and the tumor microenvironment is im...
Intact glycans from cestode antigens are involved in innate activation of myeloid suppressor cells
SUMMARY During helminthic infections, strong Th2 type‐biased responses concomitant with impaired cell‐proliferative responses to parasitic and unrelated antigens are major immun...
Publication Info
- Year
- 1988
- Type
- review
- Volume
- 80
- Issue
- 10
- Pages
- 722-727
- Citations
- 53
- Access
- Closed
External Links
Social Impact
Social media, news, blog, policy document mentions
Citation Metrics
Cite This
Identifiers
- DOI
- 10.1093/jnci/80.10.722
- PMID
- 3290496